{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:30Z","timestamp":1781636070805,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study assessed associations between transfusion-transmitted infections (TTIs: hepatitis B, hepatitis C, HIV, syphilis) and demographic factors (sex, age, education) including ABO\/Rh blood groups among Turkish blood donors from 2015 to 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cross-sectional analysis was performed on 56,766 donors confirmed with any TTI and permanently deferred from donation. The control group comprised 7,229,867 volunteer donors from the same period. Multivariable logistic regression analysis was conducted to assess independent associations between demographic factors and ABO\/Rh blood groups with individual TTI risks, adjusting for potential confounders. False Discovery Rate correction was applied for multiple comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall TTI prevalence was 0.779%, with HBV being most prevalent (0.594%), followed by syphilis (0.133%), HCV (0.031%), and HIV (0.024%). TTI prevalence decreased significantly over the study period. Male donors showed higher adjusted risk for all TTIs. Lower education levels (\u2264\u20098 years) were associated with increased risk for all infections. Younger donors (18\u201334 years) had lower prevalence of HBV and syphilis compared to those\u2009\u2265\u200935 years. After FDR correction, several blood group associations remained significant: Blood group B Rh(+) showed increased risk for both HBV (aOR\u2009=\u20091.059, 95% CI: 1.032\u20131.088) and syphilis (aOR\u2009=\u20091.121, 95% CI: 1.062\u20131.184). AB Rh(+) donors had increased syphilis risk (aOR\u2009=\u20091.118, 95% CI: 1.035\u20131.206). Conversely, O Rh(+) showed protective association with syphilis (aOR\u2009=\u20090.855, 95% CI: 0.817\u20130.895), while A Rh(-) demonstrated protection against HBV (aOR\u2009=\u20090.935, 95% CI: 0.894\u20130.978). No significant associations were found between blood groups and HCV or HIV infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This large-scale study demonstrates declining TTI prevalence in Turkish blood donors and identifies demographic risk factors including male sex, older age, and lower education. ABO\/Rh blood groups show statistically significant but modest associations with specific TTIs, particularly HBV and syphilis. These findings suggest blood group systems may represent non-modifiable risk factors through complex immunological mechanisms. Comprehensive molecular and genetic studies are needed to elucidate underlying mechanisms and validate these population-specific associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12842-5","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T03:45:59Z","timestamp":1770954359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between ABO\/Rh blood groups and transfusion-transmitted infections among Turkish blood donors: a comprehensive demographic analysis (2015\u20132021)"],"prefix":"10.1186","volume":"26","author":[{"given":"Aziz","family":"Karaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcr R\u00fc\u015ft\u00fc","family":"G\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Nuri","family":"G\u00fcn\u00e7\u0131kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem G\u00f6k\u00e7e","family":"Karada\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazl\u0131 Nadire","family":"S\u00f6zmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Sa\u011fdur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerem","family":"K\u0131n\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Meri\u00e7","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"12842_CR1","unstructured":"World Health Organization Model List of Essential Medicines \u2013\u200923rd list. 2023. https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.02. Accessed: 10 Jun 2025."},{"key":"12842_CR2","unstructured":"World Health Organization, Blood safety and availability (30. May 2025). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blood-safety-and-availability. Accessed: 10 Jun 2025."},{"issue":"3","key":"12842_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1128\/CMR.00109-14","volume":"28","author":"L Cooling","year":"2015","unstructured":"Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015;28(3):801\u201370. https:\/\/doi.org\/10.1128\/CMR.00109-14.","journal-title":"Clin Microbiol Rev"},{"key":"12842_CR4","unstructured":"International Society of Blood Transfusion Red Cell. (2025). Immunogenetics and blood group terminology. https:\/\/www.isbtweb.org\/isbt-working-parties\/rcibgt.html. Accessed: 10 Jun 2025."},{"issue":"6","key":"12842_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/wsbm.1355","volume":"8","author":"DR Ewald","year":"2016","unstructured":"Ewald DR, Sumner SC. Blood type biochemistry and human disease. Wiley Interdiscip Rev Syst Biol Med. 2016;8(6):517\u201335. https:\/\/doi.org\/10.1002\/wsbm.1355.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"1","key":"12842_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/bjh.14757","volume":"179","author":"SG Sandler","year":"2017","unstructured":"Sandler SG, Chen LN, Flegel WA. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype. Br J Haematol. 2017;179(1):10\u20139. https:\/\/doi.org\/10.1111\/bjh.14757.","journal-title":"Br J Haematol"},{"key":"12842_CR7","doi-asserted-by":"publisher","unstructured":"Hroob AMA, Saghir SAM, Almaiman AA, Alsalahi OSA, Al-Wajeeh AS, Al-Shargi OYA et al. Prevalence and association of transfusion transmitted infections with ABO and Rh blood groups among blood donors at the National blood Bank, Amman, Jordan. Medicina (Kaunas) 2020, 56(12):1\u201311. https:\/\/doi.org\/10.3390\/medicina56120701","DOI":"10.3390\/medicina56120701"},{"issue":"1","key":"12842_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.32007\/jfacmedbagdad.541771","volume":"54","author":"AA Omar","year":"2012","unstructured":"Omar AA, Al-Hayani NN, Mohammed MJ. The infection with HBV and HCV and their relationship to ABO blood group among blood donors. J Fac Med Baghdad. 2012;54(1):52\u20136.","journal-title":"J Fac Med Baghdad"},{"issue":"1","key":"12842_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/s1413-86702010000100009","volume":"14","author":"A Acar","year":"2010","unstructured":"Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, et al. HBV, HCV and HIV Seroprevalence among blood donors in Istanbul, turkey: how effective are the changes in the National blood transfusion policies? Braz J Infect Dis. 2010;14(1):41\u20136. https:\/\/doi.org\/10.1590\/s1413-86702010000100009.","journal-title":"Braz J Infect Dis"},{"issue":"3","key":"12842_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5222\/MMJ.2021.00921","volume":"36","author":"A Karaca","year":"2021","unstructured":"Karaca A, Guncikan MN, Sozmen NN, Karadag GG, Yilmaz M, Kinik K, et al. Longitudinal SARS-CoV-2 seroconversion course and antibody levels by blood groups in convalescent plasma donors in Turkey. Medeni Med J. 2021;36(3):185\u201392. https:\/\/doi.org\/10.5222\/MMJ.2021.00921.","journal-title":"Medeni Med J"},{"key":"12842_CR11","unstructured":"Ministry of Health of T\u00fcrkiye. National Blood and blood components preparation, use and quality assurance guide. 2016, pp. 58\u201372. (In Turkish) https:\/\/shgmkanhizmetleridb.saglik.gov.tr\/TR-71523\/ulusal-kan-ve-kan-bilesenleri-hazirlama--kullanim-ve-kalite-guvencesi-rehberi-2016.html. Accessed: 30 Aug 2025."},{"issue":"1","key":"12842_CR12","doi-asserted-by":"publisher","first-page":"20942","DOI":"10.1038\/s41598-021-00199-5","volume":"11","author":"E Gomez-de-Mariscal","year":"2021","unstructured":"Gomez-de-Mariscal E, Guerrero V, Sneider A, Jayatilaka H, Phillip JM, Wirtz D, et al. Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets. Sci Rep. 2021;11(1):20942. https:\/\/doi.org\/10.1038\/s41598-021-00199-5.","journal-title":"Sci Rep"},{"issue":"1","key":"12842_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12879-023-08792-x","volume":"23","author":"EA Butler","year":"2023","unstructured":"Butler EA, Parikh R, Grandi SM, Ray JG, Cohen E. ABO and Rh blood groups and risk of infection: systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):797. https:\/\/doi.org\/10.1186\/s12879-023-08792-x.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"12842_CR14","first-page":"981","volume":"43","author":"F Mohammadali","year":"2014","unstructured":"Mohammadali F, Pourfathollah A. Association of ABO and Rh blood groups to blood-Borne infections among blood donors in Tehran-Iran. Iran J Public Health. 2014;43(7):981\u20139.","journal-title":"Iran J Public Health"},{"issue":"11","key":"12842_CR15","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1111\/j.1537-2995.2012.03740.x","volume":"52","author":"L Al Shaer","year":"2012","unstructured":"Al Shaer L, AbdulRahman M, John TJ, AlHashimi A. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in united Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Transfusion. 2012;52(11):2300\u20139. https:\/\/doi.org\/10.1111\/j.1537-2995.2012.03740.x.","journal-title":"Transfusion"},{"issue":"10","key":"12842_CR16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.15537\/1658-3175.5398","volume":"32","author":"TM Ataallah","year":"2011","unstructured":"Ataallah TM, Hanan KA, Maysoun KS, Sadoon AA. Prevalence of hepatitis B and C among blood donors attending the National blood transfusion center in Baghdad, Iraq from 2006\u20132009. Saudi Med J. 2011;32(10):1046\u201350.","journal-title":"Saudi Med J"},{"issue":"3","key":"12842_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4274\/vhd.galenos.2024.2024-5-2","volume":"30","author":"E Zerdali","year":"2024","unstructured":"Zerdali E, Bozkurt M, Nakir \u0130Y, Pehlivano\u011flu F. Long-Term outcomes of patients with chronic hepatitis C treated with Direct-Acting antivirals in Turkey. Viral Hepat J. 2024;30(3):70\u20136. https:\/\/doi.org\/10.4274\/vhd.galenos.2024.2024-5-2.","journal-title":"Viral Hepat J"},{"issue":"4","key":"12842_CR18","doi-asserted-by":"publisher","first-page":"E618","DOI":"10.15167\/2421-4248\/jpmh2022.63.4.2731","volume":"63","author":"M Behzadifar","year":"2022","unstructured":"Behzadifar M, Azari S, Shirkhani S, Gholamrezaei S, Shahabi S, Doshmangir L, et al. Hepatitis B vaccination in iran: historical policies and programs. J Prev Med Hyg. 2022;63(4):E618\u201324. https:\/\/doi.org\/10.15167\/2421-4248\/jpmh2022.63.4.2731.","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"12842_CR19","first-page":"20","volume":"1","author":"B Sar\u0131g\u00fcl","year":"2019","unstructured":"Sar\u0131g\u00fcl B, K\u0131l\u0131n\u00e7arslan MG, Korkmazer B, \u015eahin EM. Hepatitis B immunization status of people who born after 1998 and admitted to the teritary hospital (In Turkish). Troia Med J. 2019;1(1):20\u20135.","journal-title":"Troia Med J"},{"issue":"8","key":"12842_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00103-012-1516-1","volume":"55","author":"R Offergeld","year":"2012","unstructured":"Offergeld R, Ritter S, Hamouda O. [HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008\u20132010]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(8):907\u201313. https:\/\/doi.org\/10.1007\/s00103-012-1516-1.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"1","key":"12842_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/trf.13298","volume":"56","author":"E Slot","year":"2016","unstructured":"Slot E, Janssen MP, Marijt-van der Kreek T, Zaaijer HL, van de Laar TJ. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors. Transfusion. 2016;56(1):203\u201314. https:\/\/doi.org\/10.1111\/trf.13298.","journal-title":"Transfusion"},{"issue":"1","key":"12842_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1186\/s12879-025-10882-x","volume":"25","author":"AM Kanyike","year":"2025","unstructured":"Kanyike AM, Kakuba F, Mayambala P, Nalunkuma R, Nakandi RM, Mulumba Y, et al. Prevalence trends of transfusion-transmitted infections at a tertiary private hospital blood bank in uganda: a retrospective 6-year review (2017\u20132022). BMC Infect Dis. 2025;25(1):672. https:\/\/doi.org\/10.1186\/s12879-025-10882-x.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"12842_CR23","doi-asserted-by":"publisher","first-page":"e70769","DOI":"10.1002\/hsr2.70769","volume":"8","author":"DS Gebreyes","year":"2025","unstructured":"Gebreyes DS, Kifetew K, Gizaw A, Abebe TA, Shenkutie TT, Genetu D, et al. Prevalence and risk factors of Transfusion-Transmissible infections among voluntary blood donors in North Shoa, Amhara Region, ethiopia: A Cross-Sectional study. Health Sci Rep. 2025;8(5):e70769. https:\/\/doi.org\/10.1002\/hsr2.70769.","journal-title":"Health Sci Rep"},{"issue":"1","key":"12842_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1186\/s12879-025-11024-z","volume":"25","author":"I Habibu","year":"2025","unstructured":"Habibu I, Abubakar BM, Moi IM, Abdulrazaq R. Seroprevalence of HIV, HBV, HCV and syphilis among blood donors in a Nigerian tertiary medical centre. BMC Infect Dis. 2025;25(1):638. https:\/\/doi.org\/10.1186\/s12879-025-11024-z.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"12842_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/vox.13592","volume":"119","author":"HM Faddy","year":"2024","unstructured":"Faddy HM, Osiowy C, Custer B, Busch M, Stramer SL, Adesina O, et al. International review of blood donation nucleic acid amplification testing. Vox Sang. 2024;119(4):315\u201325. https:\/\/doi.org\/10.1111\/vox.13592.","journal-title":"Vox Sang"},{"key":"12842_CR26","unstructured":"The Turkish Red Crescent General Directorate of Blood Services Annual Report. 2021:91. https:\/\/www.kanver.org\/Upload\/Dokuman\/Dosya\/gdbs-2021-21-07-2022-80078671.pdf. Accessed: 10 Jun 2025."},{"issue":"11","key":"12842_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","volume":"21","author":"N Tozun","year":"2015","unstructured":"Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2015.06.028.","journal-title":"Clin Microbiol Infect"},{"key":"12842_CR28","doi-asserted-by":"publisher","first-page":"233339282211367","DOI":"10.1177\/23333928221136717","volume":"9","author":"A Aliyo","year":"2022","unstructured":"Aliyo A, Ashenafi G, Adem S. Evaluation of transfusion transmissible infections prevalence and trend among blood donors attended at bule hora blood Bank, West Guji, South Ethiopia. Health Serv Res Manag Epidemiol. 2022;9:23333928221136717. https:\/\/doi.org\/10.1177\/23333928221136717.","journal-title":"Health Serv Res Manag Epidemiol"},{"issue":"9","key":"12842_CR29","doi-asserted-by":"publisher","first-page":"e70469","DOI":"10.7759\/cureus.70469","volume":"16","author":"S Deshmukh","year":"2024","unstructured":"Deshmukh S, Rathod Y, Thakore S, Jadhav S. Prevalence of Transfusion-Transmissible infections among voluntary blood donors in a tertiary care hospital. Cureus. 2024;16(9):e70469. https:\/\/doi.org\/10.7759\/cureus.70469.","journal-title":"Cureus"},{"key":"12842_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.12688\/wellcomeopenres.17601.2","volume":"7","author":"R Brown","year":"2022","unstructured":"Brown R, Goulder P, Matthews PC. Sexual dimorphism in chronic hepatitis B virus (HBV) infection: evidence to inform elimination efforts. Wellcome Open Res. 2022;7:32. https:\/\/doi.org\/10.12688\/wellcomeopenres.17601.2.","journal-title":"Wellcome Open Res"},{"key":"12842_CR31","unstructured":"Liu AY, Buchbinder SPCROI. 2024: Global epidemiology and prevention of HIV and other sexually transmitted diseases. Top Antivir Med 2024;32(3):447\u2009\u2013\u200982."},{"issue":"10","key":"12842_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338. https:\/\/doi.org\/10.1038\/nri.2016.90.","journal-title":"Nat Rev Immunol"},{"key":"12842_CR33","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3389\/fimmu.2018.01931","volume":"9","author":"V Taneja","year":"2018","unstructured":"Taneja V. Sex hormones determine immune response. Front Immunol. 2018;9:1931. https:\/\/doi.org\/10.3389\/fimmu.2018.01931.","journal-title":"Front Immunol"},{"key":"12842_CR34","doi-asserted-by":"publisher","unstructured":"Souyris M, Cenac C, Azar P, Daviaud D, Canivet A, Grunenwald S, et al. TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol. 2018;3(19). https:\/\/doi.org\/10.1126\/sciimmunol.aap8855.","DOI":"10.1126\/sciimmunol.aap8855"},{"key":"12842_CR35","doi-asserted-by":"publisher","first-page":"eAO6934","DOI":"10.31744\/einstein_journal\/2022AO6934","volume":"20","author":"BGD Silva","year":"2022","unstructured":"Silva BGD, Ferreira LH, Ribeiro CEL, Raboni SM. HIV, syphilis, hepatitis B and C in key populations: results of a 10-year cross-sectional study, Southern Brazil. Einstein (Sao Paulo). 2022;20:eAO6934. https:\/\/doi.org\/10.31744\/einstein_journal\/2022AO6934.","journal-title":"Einstein (Sao Paulo)"},{"issue":"9","key":"12842_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1258\/ijsa.2012.011411","volume":"23","author":"YS Zhao","year":"2012","unstructured":"Zhao YS, Su SI, Lv CX, Zhang XF, Lin L, Sun XG, et al. Seroprevalence of hepatitis C, hepatitis B virus and syphilis in HIV-1 infected patients in Shandong, China. Int J STD AIDS. 2012;23(9):639\u201343. https:\/\/doi.org\/10.1258\/ijsa.2012.011411.","journal-title":"Int J STD AIDS"},{"key":"12842_CR37","doi-asserted-by":"publisher","unstructured":"Kopacz A, Kubicka-Russel D, Liszewski G, Sulkowska E, Chrzanowska A, Zwolinska P, et al. Hepatitis B virus in Polish blood donors in the period 2005-2019-Significant changes in epidemiology and demographic characteristics of infected donors. Viruses. 2025;17(1). https:\/\/doi.org\/10.3390\/v17010060.","DOI":"10.3390\/v17010060"},{"key":"12842_CR38","doi-asserted-by":"publisher","unstructured":"Theodorakis N, Feretzakis G, Hitas C, Kreouzi M, Kalantzi S, Spyridaki A, et al. Immunosenescence: how aging increases susceptibility to bacterial infections and virulence factors. Microorganisms. 2024;12(10). https:\/\/doi.org\/10.3390\/microorganisms12102052.","DOI":"10.3390\/microorganisms12102052"},{"issue":"52","key":"12842_CR39","doi-asserted-by":"publisher","first-page":"21432","DOI":"10.1073\/pnas.1209283110","volume":"109","author":"PL Johnson","year":"2012","unstructured":"Johnson PL, Yates AJ, Goronzy JJ, Antia R. Peripheral selection rather than thymic Involution explains sudden contraction in Naive CD4 T-cell diversity with age. Proc Natl Acad Sci U S A. 2012;109(52):21432\u20137. https:\/\/doi.org\/10.1073\/pnas.1209283110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"12842_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0889-8561(02)00056-5","volume":"23","author":"H Bruunsgaard","year":"2003","unstructured":"Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am. 2003;23(1):15\u201339. https:\/\/doi.org\/10.1016\/s0889-8561(02)00056-5.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"12842_CR41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12879-019-4044-x","volume":"19","author":"L Chang","year":"2019","unstructured":"Chang L, Zhao J, Guo F, Ji H, Zhang L, Jiang X, et al. Demographic characteristics of transfusion-transmitted infections among blood donors in China. BMC Infect Dis. 2019;19(1):514. https:\/\/doi.org\/10.1186\/s12879-019-4044-x.","journal-title":"BMC Infect Dis"},{"key":"12842_CR42","doi-asserted-by":"publisher","unstructured":"Bartonjo G, Oundo J, Ng\u2019ang\u2019a Z. Prevalence and associated risk factors of transfusion transmissible infections among blood donors at regional blood transfusion center Nakuru and Tenwek mission Hospital, Kenya. Pan Afr Med J 2019, 34:31. https:\/\/doi.org\/10.11604\/pamj.2019.34.31.17885","DOI":"10.11604\/pamj.2019.34.31.17885"},{"issue":"1","key":"12842_CR43","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.1038\/s41598-024-58284-4","volume":"14","author":"NK Eltewacy","year":"2024","unstructured":"Eltewacy NK, Ali HT, Owais TA, Alkanj S, Collaborators E, Ebada MA. Unveiling blood donation knowledge, attitude, and practices among 12,606 university students: a cross-sectional study across 16 countries. Sci Rep. 2024;14(1):8219. https:\/\/doi.org\/10.1038\/s41598-024-58284-4.","journal-title":"Sci Rep"},{"issue":"3","key":"12842_CR44","doi-asserted-by":"publisher","first-page":"e0249061","DOI":"10.1371\/journal.pone.0249061","volume":"16","author":"A Mremi","year":"2021","unstructured":"Mremi A, Yahaya JJ, Nyindo M, Mollel E. Transfusion-Transmitted infections and associated risk factors at the Northern zone blood transfusion center in tanzania: A study of blood donors between 2017 and 2019. PLoS ONE. 2021;16(3):e0249061. https:\/\/doi.org\/10.1371\/journal.pone.0249061.","journal-title":"PLoS ONE"},{"key":"12842_CR45","doi-asserted-by":"publisher","unstructured":"Altayar MA, Jalal MM, Kabrah A, Qashqari FSI, Jalal NA, Faidah H, et al. Prevalence and association of transfusion transmitted infections with ABO and Rh blood groups among blood donors in the Western region of Saudi arabia: A 7-Year retrospective analysis. Med (Kaunas). 2022;58(7). https:\/\/doi.org\/10.3390\/medicina58070857.","DOI":"10.3390\/medicina58070857"},{"issue":"9","key":"12842_CR46","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.18203\/2320-6012.ijrms20173949","volume":"5","author":"O Genc","year":"2017","unstructured":"Genc O. Hepatitis B virus infection and ABO\/Rh blood groups. Int J Res Med Sci. 2017;5(9):3782\u20135. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20173949.","journal-title":"Int J Res Med Sci"},{"issue":"13","key":"12842_CR47","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1096\/fasebj.12.13.1255","volume":"12","author":"MB Oldstone","year":"1998","unstructured":"Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J. 1998;12(13):1255\u201365. https:\/\/doi.org\/10.1096\/fasebj.12.13.1255.","journal-title":"FASEB J"},{"key":"12842_CR48","doi-asserted-by":"publisher","first-page":"100217","DOI":"10.1016\/j.microb.2024.100217","volume":"5","author":"LS Santos","year":"2024","unstructured":"Santos LS, Fernandes SES, Amorim FFP, Sant\u2019Anna ALO, Amorim FFP, Amorim FF. The link between ABO and Rh(D) blood groups with transfusion-transmitted infections in a public blood center in a Brazilian metropolitan area. Microbe. 2024;5:100217. https:\/\/doi.org\/10.1016\/j.microb.2024.100217.","journal-title":"Microbe"},{"issue":"4","key":"12842_CR49","first-page":"1","volume":"5","author":"Z Naseri","year":"2016","unstructured":"Naseri Z, Ghannad MS, Hosseini SM, Roshanaei G, Nejad ASM, Mohammadi A. Evaluation of accompaniment of ABO blood groups system and rhesus blood group types with infection to hepatitis B virus and hepatitis C virus in Hamadan, Iran. Int J Med Res Health Sci. 2016;5(4):1\u20135.","journal-title":"Int J Med Res Health Sci"},{"issue":"1","key":"12842_CR50","doi-asserted-by":"publisher","first-page":"e034114","DOI":"10.1136\/bmjopen-2019-034114","volume":"10","author":"W Jing","year":"2020","unstructured":"Jing W, Zhao S, Liu J, Liu M. ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis. BMJ Open. 2020;10(1):e034114. https:\/\/doi.org\/10.1136\/bmjopen-2019-034114.","journal-title":"BMJ Open"},{"issue":"1","key":"12842_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5455\/jrmds.20164113","volume":"4","author":"S Bharadva","year":"2016","unstructured":"Bharadva S, Vachhani J, Dholakiya S. ABO and Rh association to transfusion transmitted infections among healthy blood donors in Jamnagar, Gujarat, India. J Res Med Dent Sci. 2016;4(1):58\u201361.","journal-title":"J Res Med Dent Sci"},{"issue":"4","key":"12842_CR52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/jvh.12829","volume":"25","author":"J Liu","year":"2018","unstructured":"Liu J, Zhang S, Liu M, Wang Q, Shen H, Zhang Y. Distribution of ABO\/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: A population-based cross-sectional study. J Viral Hepat. 2018;25(4):401\u201311. https:\/\/doi.org\/10.1111\/jvh.12829.","journal-title":"J Viral Hepat"},{"key":"12842_CR53","doi-asserted-by":"publisher","unstructured":"Herrscher C, Roingeard P, Blanchard E. Hepatitis B virus entry into cells. Cells. 2020;9(6). https:\/\/doi.org\/10.3390\/cells9061486.","DOI":"10.3390\/cells9061486"},{"issue":"24","key":"12842_CR54","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1016\/j.vaccine.2023.04.051","volume":"41","author":"A Berry","year":"2023","unstructured":"Berry A, Kapelus D, Singh P, Groome M, de Assis Rosa D. ABO blood types, but not secretor or Lewis blood types, influence strength of antibody response to hepatitis B vaccine in black South African children. Vaccine. 2023;41(24):3617\u201326. https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.051.","journal-title":"Vaccine"},{"issue":"16","key":"12842_CR55","doi-asserted-by":"publisher","first-page":"9049","DOI":"10.1128\/JVI.01161-14","volume":"88","author":"R Julithe","year":"2014","unstructured":"Julithe R, Abou-Jaoude G, Sureau C. Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies. J Virol. 2014;88(16):9049\u201359. https:\/\/doi.org\/10.1128\/JVI.01161-14.","journal-title":"J Virol"},{"issue":"4","key":"12842_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.18231\/j.achr.2022.051","volume":"7","author":"RJ Shah","year":"2022","unstructured":"Shah RJ, Patel D. Correlation of ABO-Rh blood group and transfusion transmitted infections (TTI) among blood donors. IP Archives Cytol Histopathology Res. 2022;7(4):229\u201332. https:\/\/doi.org\/10.18231\/j.achr.2022.051.","journal-title":"IP Archives Cytol Histopathology Res"},{"issue":"4","key":"12842_CR57","first-page":"1700","volume":"14","author":"SA Hassan","year":"2020","unstructured":"Hassan SA, Nassir ES, Ibrahim AI, Tareq L. Seroprevalence of syphilis among iraq\u2019s blood donors and their relation with blood group and Rh factor. Indian J Forensic Med Toxicol. 2020;14(4):1700\u20136.","journal-title":"Indian J Forensic Med Toxicol"},{"issue":"1","key":"12842_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4274\/haseki.galenos.2021.7235","volume":"59","author":"M Y\u0131lmaz","year":"2021","unstructured":"Y\u0131lmaz M, Karaca A, Sozmen NN, Guncikan MN, Karadag GG, Hafizoglu N, et al. Association between COVID-19 and ABO blood groups: an analysis on convalescent plasma donors in Turkey. Med Bull Haseki. 2021;59(1):7\u201314. https:\/\/doi.org\/10.4274\/haseki.galenos.2021.7235.","journal-title":"Med Bull Haseki"},{"issue":"3","key":"12842_CR59","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1128\/iai.60.3.1076-1083.1992","volume":"60","author":"DL Cox","year":"1992","unstructured":"Cox DL, Chang P, McDowall AW, Radolf JD. The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum. Infect Immun. 1992;60(3):1076\u201383. https:\/\/doi.org\/10.1128\/iai.60.3.1076-1083.1992.","journal-title":"Infect Immun"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12842-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:12:22Z","timestamp":1781633542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12842"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12842-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7476627\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by TRC Research Ethics Committee (Approval number: 2022\/05; 10.05.2022). All methods were performed in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki. This study involved blood donors who completed a predonation questionnaire to assess their eligibility. The questionnaire includes a statement indicating that their data may be used for scientific research and that donors provide written consent by signing the form. Therefore, no additional informed consent was obtained. All the data were retrieved from the Turkish Red Crescent database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}